|
Q2 FY2026
As of Jul 5, 2026
|
Q1 FY2026
As of Apr 5, 2026
|
Q4 FY2025
As of Dec 28, 2025
|
Q3 FY2025
As of Sep 28, 2025
|
Q2 FY2025
As of Jun 29, 2025
|
Q1 FY2025
As of Mar 30, 2025
|
Q4 FY2024
As of Dec 29, 2024
|
Q3 FY2024
As of Sep 29, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Oct 1, 2023
|
Q2 FY2023
As of Jul 2, 2023
|
Q1 FY2023
As of Apr 2, 2023
|
Q4 FY2022
As of Jan 1, 2023
|
Q3 FY2022
As of Oct 2, 2022
|
Q2 FY2022
As of Jul 3, 2022
|
Q1 FY2022
As of Apr 3, 2022
|
Q4 FY2021
As of Jan 2, 2022
|
Q3 FY2021
As of Oct 3, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Notes receivable, net | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Deferred contract costs | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Long-term investments | ||||||||||||||||||||
| Customer relationship intangibles and other intangibles, net | ||||||||||||||||||||
| Operating lease, right-of-use assets | ||||||||||||||||||||
| Deferred contract costs, non-current | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets, non-current | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Short-term debt | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Warrant liability, non-current | ||||||||||||||||||||
| Operating lease liabilities, non-current | ||||||||||||||||||||
| Deferred revenue, non-current | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Other liabilities, non-current | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock, $0.0001 par value; authorized shares of 1,000,000,000; issued and outstanding shares of $219,195,932 and $216,556,238 as of July 5, 2026 and December 28, 2025, respectively | ||||||||||||||||||||
| Preferred stock, $0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of December 29, 2024 and December 31, 2023, respectively | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Treasury stock, at cost | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Enovix’s stockholders’ equity | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
